课题基金 / 基金详情

CONSTITUTIVELY ACTIVE DOPAMINE D1 AND D2 RECEPTORS

CONSTITUTIVELY ACTIVE DOPAMINE D1 AND D2 RECEPTORS
组成型活性多巴胺 D1 和 D2 受体
批准号:
6538813
负责人:
QUN-YONG ZHOU
金额:
$10.83万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-07-01 至 2004-06-30

项目摘要

项目成果

QUN-YONG ZHOU的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Adapted from applicant's abstract): The long-term objective of this project is to further our understanding of the physiological role of dopamine D1 and D2 receptors in normal CNS function and in the functional pathologies associated with schizophrenia and other mental health disorders. Evidence put forth by a number of investigators suggests that the overactivation of dopaminergic synaptic transmission may be important in the pathophysiology of schizophrenia. The precise relation of dopamine overactivation to schizophrenia, however, remaines vague. The present series of studies seeks to bridge this gap by investigating the consequences of overactivated dopamine systems on brain development and function by genetic manipulation of dopamine receptors, and by identifying the consequences of expression of mutant dopamine receptors in transgenic animals. In brief, these studies seek (a) to create constitutively active mutants of dopamine D1 and D2 receptors and to identify their pharmacological and biochemical characteristics, (b) to introduce selected constitutively active D1 and D2 receptor mutants into transgenic mice, (c) to characterize developmental abnormalities in animals with overactivated dopamine systems, and (d) to identify behavioral abnormalities in mice with constitutively active dopamine receptors. The studies will enhance our understanding of D1 and D2 receptors at the molecular level, lead to a better understanding of the action mechanisms for dopamine receptors, and may lead to the development of improved pharmacotherapies for dopamine system malfunctions. These studies will also lead to a better understanding of the developmental and functional consequences of dopamine overactivation and should provide us with some fundamental information pertaining to the relation of dopamine neurotransmission malfunctions with the development of the behavioral malfunctions underlying complex mental health disorders.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
Association of dopamine D(3) receptors with actin-binding protein 280 (ABP-280).
多巴胺 D(3) 受体与肌动蛋白结合蛋白 280 (ABP-280) 的关联。
DOI: 10.1016/s0006-2952(01)00932-7
发表时间: 2002
期刊: Biochemical pharmacology
影响因子: 5.8
作者: [Li,Ming, Li,Chuanyu, Weingarten,Paul, Bunzow,JamesR, Grandy,DavidK, Zhou,QunYong]
通讯作者: Zhou,QunYong
Accessory proteins in the biogenesis of G protein-coupled receptors.
G 蛋白偶联受体生物发生中的辅助蛋白。
DOI: --
发表时间: 2001
期刊: Molecular interventions.
影响因子: --
作者: [Bermak,JC, Zhou,QY]
通讯作者: Zhou,QY
Evidence for non-oxidative dopamine cytotoxicity: potent activation of NF-kappa B and lack of protection by anti-oxidants.
非氧化性多巴胺细胞毒性的证据:NF-κ B 的有效激活且缺乏抗氧化剂的保护。
DOI: 10.1046/j.1471-4159.2001.00190.x
发表时间: 2001
期刊: Journal of neurochemistry
影响因子: 4.7
作者: [Weingarten,P, Bermak,J, Zhou,QY]
通讯作者: Zhou,QY
Regulation of glucose homeostasis by prokineticin 2 signaling
  • 批准号:
    8095574
  • 项目类别:
  • 资助金额:
    $24.02万
  • 财政年份:
    2011
  • 负责人:
    QUN-YONG ZHOU
  • 依托单位:
Regulation of glucose homeostasis by prokineticin 2 signaling
  • 批准号:
    8313920
  • 项目类别:
  • 资助金额:
    $18.87万
  • 财政年份:
    2011
  • 负责人:
    QUN-YONG ZHOU
  • 依托单位:
Prokineticin 2 and Suprachiasmatic Circadian Output
  • 批准号:
    7093485
  • 项目类别:
  • 资助金额:
    $35.72万
  • 财政年份:
    2004
  • 负责人:
    QUN-YONG ZHOU
  • 依托单位:
Prokineticin 2 and Suprachiasmatic Circadian Output
  • 批准号:
    6952007
  • 项目类别:
  • 资助金额:
    $36.8万
  • 财政年份:
    2004
  • 负责人:
    QUN-YONG ZHOU
  • 依托单位:
海外基金